---
title: "Veraxa Biotech names Christoph Erkel chief scientific officer, succeeding Rick Austin"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293603665.md"
description: "Veraxa Biotech has appointed Christoph Erkel as its new Chief Scientific Officer, effective immediately. He succeeds Rick Austin, who will exit the company after a transition period. Erkel brings 20 years of experience in antibody therapeutics and previously led immuno-oncology programs at MorphoSys. His role involves driving the development of Veraxa's BiTAC platform and oncology pipeline."
datetime: "2026-07-23T11:02:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293603665.md)
  - [en](https://longbridge.com/en/news/293603665.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293603665.md)
---

# Veraxa Biotech names Christoph Erkel chief scientific officer, succeeding Rick Austin

-   Veraxa Biotech named Christoph Erkel chief scientific officer, effective immediately, to drive development of its BiTAC platform and oncology pipeline. \* Erkel was previously vice president of R&D; his background includes 20 years in antibody therapeutics spanning discovery through IND submission. \* He previously led immuno-oncology programs at MorphoSys, including conditionally active T-cell engagers, following roles at Sloning BioTechnology. \* Rick Austin will exit the company following a transition period. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veraxa Biotech AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607230700OMX\_\_\_\_\_CNEWS\_EN\_GNW1001214113\_en) on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [VRXA.US](https://longbridge.com/en/quote/VRXA.US.md)
- [MOR.DE](https://longbridge.com/en/quote/MOR.DE.md)

## Related News & Research

- [Veraxa Biotech files first BiTAC-related patent applications for cancer therapy platforms](https://longbridge.com/en/news/294550628.md)
- [Veraxa Biotech receives PEI scientific advice on BiTAC-TCE development plan](https://longbridge.com/en/news/293203327.md)
- [OGE Energy names former Devon Energy CEO Rick Muncrief to board](https://longbridge.com/en/news/294736904.md)
- [Sartorius Stedim Biotech reports 97,330,405 issued shares, 164,721,373 net voting rights as of July 31, 2026](https://longbridge.com/en/news/294788646.md)
- [Business First Bancshares director Rick D. Day acquires 1,500 common shares valued at $47,415](https://longbridge.com/en/news/294255382.md)